Tue, 27 Oct 2026
08:29:40 pm
Rudransh Sangwan
Published at: October 27, 2026, 5:28 PM
Synopsis
Bengaluru-based Cent AI raises $15 million in Series A funding led by investors including Blume Ventures and South Park Commons to expand AI-powered preventive healthcare, medical technology and clinical research.

Bengaluru-based healthcare startup Cent AI (Centai Technologies Private Limited) has raised $15 million in a Series A funding round. The round included participation from Blume Ventures, South Park Commons and several individual investors.
Founded by Shashank ND, Arpit Garg and Anshul Khandelwal, Cent AI offers preventive healthcare services focused on early disease detection and health screening.
| Particulars | Details |
|---|---|
| Funding amount | $15 million |
| Funding round | Series A |
| Company | Cent AI |
| Sector | Healthcare |
| Headquarters | Bengaluru, India |
| Founders | Shashank ND, Arpit Garg, Anshul Khandelwal |
| Investors | Blume Ventures, South Park Commons and individual investors |
Other participants included Arun Sarin, Srinivas Narayan, Sharath Narayanan of Sanas AI, Aprameya Radhakrishna of TaxiForSure and Krishan Sridhar.
Cent AI plans to invest in medical hardware, artificial intelligence capabilities and clinical research. The funding is intended to support the development of its screening technology and preventive healthcare services.
Cent AI provides health screening packages that combine medical scans, blood tests and AI-powered analysis. Its services include:
Customers can book packages online, arrange at-home blood collection and undergo scans at partner centres. The company provides doctor-reviewed digital reports featuring organ-wise health scores, biological age tracking, risk alerts and personalised recommendations.
Cent AI’s latest funding is expected to support further investment in its technology, medical infrastructure and clinical research as it develops its preventive healthcare services.
This article is for informational purposes only and does not constitute investment advice.
Cent AI has raised $15 million in a Series A funding round. The funding will support investments in medical hardware, artificial intelligence capabilities and clinical research.
The round included participation from Blume Ventures, South Park Commons and individual investors, including Arun Sarin, Srinivas Narayan, Sharath Narayanan, Aprameya Radhakrishna and Krishan Sridhar.
Cent AI, operated by Centai Technologies Private Limited, was founded by Shashank ND, Arpit Garg and Anshul Khandelwal. The Bengaluru-based startup focuses on preventive healthcare and early disease detection.
Cent AI plans to invest in medical hardware, AI capabilities and clinical research. These investments are intended to support the development of its screening technology and preventive healthcare services.
Cent AI offers health screening packages that can include full-body MRI, CT calcium scoring, DEXA scans, chest X-rays, ECG tests and blood tests. Package availability depends on the services selected.
Cent AI combines medical screening data with AI-powered analysis to provide digital health reports featuring organ-wise scores, biological age tracking, risk alerts and personalised recommendations, with doctor review.
Cent AI offers screening services that may help identify potential health concerns, including full-body MRI and CT calcium scoring. However, screening cannot detect every cancer or predict every heart problem, and abnormal findings may require further medical evaluation.
Cent AI allows customers to book packages online, arrange at-home blood collection and undergo scans at partner centres. Customers should check the company's current service locations, package inclusions and eligibility requirements before booking.

Financial journalist specializing in market analysis, stock research, and investment trends. Dedicated to providing accurate, timely insights for informed decision-making.
Credentials: Experienced financial journalist with expertise in equity markets and economic analysis
The information provided in this article is for educational and informational purposes only and should not be construed as financial, investment, or legal advice. welomoney does not provide personalized investment recommendations.
For detailed terms and conditions, please read our Disclaimer and Terms of Service.
No additional articles in this category yet.